The YDL186W locus is annotated in the Saccharomyces Genome Database (SGD) as a hypothetical open reading frame (ORF) with no experimentally confirmed molecular function to date . Key features include:
Genomic Location: Chromosome IV (nucleotides 218,983–220,128).
Protein Length: 381 amino acids.
Conservation: Limited homology to other characterized proteins, suggesting a yeast-specific or uncharacterized role.
While no direct studies on "YDL186W Antibody" exist, yeast is widely used for antibody production and secretion studies. For example:
Antibody Secretion Engineering: Overexpression of genes like IRE1, GOT1, and HUT1 in S. cerevisiae enhances IgG secretion by 3–6.5-fold .
Strain Optimization: Deletion or overexpression of specific genes (e.g., OYE2, OYE3) can improve resistance to toxins like acrolein, indirectly supporting antibody production workflows .
The table below summarizes genes implicated in yeast-based antibody engineering, based on recent studies:
Functional Characterization: Epitope tagging or immunoprecipitation using a YDL186W-specific antibody could elucidate its role.
Industrial Relevance: If YDL186W impacts secretory pathways (e.g., glycosylation, stress response), it might affect antibody yields .
YDL186W is a gene locus in Saccharomyces cerevisiae (strain ATCC 204508/S288c), encoding a specific protein with UniProt accession number P48568. The antibody against this protein serves as an essential tool for studying protein expression, localization, and function in this model organism. S. cerevisiae has been extensively used as a eukaryotic model system due to its genetic tractability, rapid growth, and conserved cellular processes shared with higher eukaryotes including humans .
When designing experiments with YDL186W antibody, researchers should consider the following methodological approach:
Determine the specific research question (protein localization, expression level, protein-protein interactions)
Select appropriate experimental techniques (immunoblotting, immunoprecipitation, immunofluorescence)
Include proper controls (wild-type and deletion strains)
Optimize antibody concentration based on preliminary titration experiments
YDL186W antibody should be stored at -20°C for long-term storage and can be kept at 4°C for up to one month during active use. To maintain antibody integrity, consider the following methodological practices:
Aliquot the antibody upon first thawing to avoid repeated freeze-thaw cycles
Store in small volumes (50-100 μL) to minimize waste and degradation
Always centrifuge the vial briefly before opening to collect all liquid at the bottom
Add a carrier protein (0.1% BSA) if diluting the antibody for long-term storage
Avoid exposure to light when working with fluorophore-conjugated versions
Validating antibody specificity is crucial for reliable research outcomes. For YDL186W antibody, implement the following methodological approach:
Perform western blot analysis using wild-type yeast strains alongside a YDL186W deletion strain (Δydl186w) as a negative control
Compare expression patterns in different growth phases and conditions
Use epitope-tagged versions of the protein for parallel detection with tag-specific antibodies
Preabsorb the antibody with purified antigen to confirm signal specificity
Consider peptide competition assays to validate epitope-specific binding
For researchers targeting chromatin-associated functions, optimizing YDL186W antibody for ChIP requires several methodological considerations:
Crosslinking optimization: Test both formaldehyde (1-3%) concentrations and crosslinking times (10-20 minutes) to preserve protein-DNA interactions while maintaining epitope accessibility
Sonication parameters: Optimize fragmentation to achieve 200-500 bp DNA fragments (verify by agarose gel electrophoresis)
Antibody amount: Perform titration experiments using 2-10 μg of antibody per reaction
Pre-clearing step: Implement with protein A/G beads to reduce background
Washing stringency: Develop a washing protocol that removes non-specific interactions while preserving specific binding
Elution conditions: Test various elution buffers to maximize recovery of immunoprecipitated material
Controls: Always include input DNA, IgG control, and, ideally, a strain lacking YDL186W
When facing contradictory data between different experimental approaches, consider this methodological framework:
Epitope masking assessment: Determine if protein interactions or post-translational modifications might obscure the epitope in certain cellular compartments
Fixation optimization: Test multiple fixation protocols (paraformaldehyde vs. methanol) as they differentially affect epitope preservation
Detergent selection: Evaluate various detergents for cell permeabilization that may influence epitope accessibility
Growth condition standardization: Ensure identical growth conditions (medium, growth phase, temperature) across experiments
Complementary approaches: Implement C-terminal and N-terminal tagging strategies to verify if tag positioning affects localization
Super-resolution microscopy: Apply advanced imaging techniques to resolve fine subcellular structures
Quantitative co-localization: Use fluorescent markers for specific organelles alongside YDL186W antibody staining with statistical co-localization analysis
For isolating native protein complexes containing YDL186W-encoded protein:
Antibody coupling: Covalently couple purified YDL186W antibody to activated agarose or magnetic beads using optimized coupling chemistry
Extract preparation: Develop gentle lysis conditions to preserve native protein interactions (consider testing different buffers with varying salt concentrations and detergents)
Pre-clearing step: Implement to reduce non-specific binding
Binding conditions: Optimize temperature (4°C is standard), time (2-16 hours), and buffer composition
Washing strategy: Develop a stepwise washing protocol with increasing stringency
Elution methods: Test competitive elution with peptide, pH gradient elution, or direct boiling in SDS sample buffer
Complex verification: Analyze by mass spectrometry and confirm interactions with targeted co-immunoprecipitation experiments
To systematically analyze YDL186W protein expression throughout yeast growth phases:
Culture synchronization: Implement alpha-factor arrest-release, nitrogen starvation, or elutriation to achieve synchronized populations
Time-point selection: Sample at regular intervals spanning lag, log, diauxic shift, and stationary phases
Growth monitoring: Track culture density using OD600 measurements at each sampling point
Standardized extraction: Use a consistent protein extraction method, preferably with mechanical disruption (e.g., glass beads) in the presence of protease inhibitors
Quantification approach: Implement quantitative western blotting with internal loading controls (e.g., Pgk1 or Act1)
Statistical analysis: Perform at least three biological replicates with appropriate statistical tests
Complementary techniques: Consider using flow cytometry for single-cell analysis if antibody works for this application
A methodologically sound co-immunoprecipitation experiment requires these controls:
Input control: Sample of the total lysate before immunoprecipitation (typically 5-10%)
No-antibody control: Beads only, to identify proteins that bind non-specifically to the matrix
Isotype control: Irrelevant antibody of the same isotype to identify proteins that bind non-specifically to immunoglobulins
Reciprocal IP: When possible, perform reverse co-immunoprecipitation using antibodies against suspected interaction partners
Genetic controls: Include strains with the gene deleted, or with point mutations affecting the interaction
DNase/RNase treatment: To exclude DNA/RNA-mediated interactions, especially for nuclear proteins
Detergent titration: Test increasing detergent concentrations to determine the specificity and strength of interactions
For optimal western blot results with YDL186W antibody:
Sample preparation:
Include protease inhibitors in lysis buffer
Optimize protein extraction using mechanical disruption for yeast cells
Determine optimal protein loading amount (typically 10-30 μg)
Gel selection:
Choose appropriate acrylamide percentage based on protein size
Consider gradient gels for better resolution
Transfer optimization:
Test different transfer methods (wet, semi-dry) and buffer compositions
Optimize transfer time and voltage based on protein size
Blocking conditions:
Test different blocking agents (5% non-fat milk, 3-5% BSA)
Determine optimal blocking time (1-3 hours or overnight)
Antibody incubation:
Test dilution ranges (1:500-1:5000) and incubation times
Optimize temperature conditions (room temperature vs. 4°C)
Detection system:
Compare chemiluminescence, fluorescence, or colorimetric detection
Consider signal enhancement systems for low-abundance proteins
Quantification:
For accurate quantification and comparison of YDL186W protein levels:
Internal loading controls: Use housekeeping proteins that remain stable under your experimental conditions
For general conditions: Pgk1, Act1, or Tub1
For stress conditions: Validate stability of potential loading controls under your specific conditions
Total protein normalization:
Consider using total protein staining methods (Ponceau S, SYPRO Ruby, stain-free technology)
Quantify total lane protein for normalization instead of single reference proteins
Spike-in controls:
Add known quantities of recombinant protein or peptide standards for absolute quantification
Statistical handling:
Perform at least three biological replicates
Apply appropriate statistical tests based on data distribution
Consider using ANOVA with post-hoc tests for multiple condition comparisons
Data visualization:
To differentiate between post-translational modifications (PTMs) and degradation products:
Molecular weight analysis:
Compare observed bands with theoretical molecular weight
Create calibration curves using protein standards
PTM-specific treatments:
Phosphatase treatment to remove phosphorylation
Deglycosylation enzymes for glycosylation
Ubiquitin-specific proteases for deubiquitination
Inhibitor treatments:
Add protease inhibitors during sample preparation
Include phosphatase inhibitors for phosphorylation studies
Use specific PTM pathway inhibitors during cell culture
Genetic approaches:
Compare wild-type with strains carrying mutations at predicted modification sites
Use strains with deletions of genes encoding modification enzymes
Complementary techniques:
Mass spectrometry for precise identification of modifications
2D gel electrophoresis to separate isoforms
Phospho-specific or other PTM-specific antibodies
Degradation assessment:
To validate and establish biological relevance of protein interactions:
Confirmation strategies:
Reciprocal co-immunoprecipitation
Proximity ligation assays
FRET or BiFC for in vivo interaction validation
Surface plasmon resonance for binding kinetics
Specificity assessment:
Test interaction under different buffer conditions (salt, detergent)
Compare with closely related proteins as specificity controls
Include domain deletion mutants to map interaction regions
Functional validation:
Genetic interaction studies (synthetic lethality/sickness)
Phenotypic analysis of interaction-deficient mutants
Localization studies to confirm co-localization
Network analysis:
Compare with published interactome data
Perform GO term enrichment analysis
Consider protein complex prediction algorithms
Evolutionary conservation:
Test conservation of interaction in other yeast species
Examine if mammalian orthologs maintain similar interactions
Quantitative considerations:
Selection of appropriate yeast strains is critical for YDL186W antibody experiments:
When selecting strains, consider these methodological principles:
Use isogenic strains for comparative studies to minimize genetic background effects
Include deletion strains (Δydl186w) as negative controls
Consider protease-deficient strains (Δpep4, Δprb1) when studying unstable proteins
For subcellular localization studies, utilize strains with fluorescently marked organelles
In interaction studies, consider tagged versions of candidate interacting proteins
Genetic background can significantly impact experimental results with YDL186W antibody:
Strain-specific effects:
Expression levels of YDL186W may vary between laboratory strains (W303, S288C, BY4741)
Post-translational modification patterns might differ between genetic backgrounds
Protein stability can be affected by strain-specific protease expression
Methodological approaches to address background effects:
Always compare within the same genetic background
When changing backgrounds, validate antibody performance in each strain
Consider backcrossing mutations of interest to establish isogenic controls
Quantify relative expression levels in different backgrounds using calibrated western blotting
Include multiple strain backgrounds for critical experiments to establish robustness
Specific considerations for common laboratory strains: